Mahua Bhattacharya

Dr. Mahua Bhattacharya

Bar-Ilan University, Ramat Gan, Tel Aviv, Israel
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
EMEli Magen
Eli Magen
Sumit MukherjeeSumit Mukherjee
Sumit Mukherjee
MBMahua Bhattacharya
Mahua Bhattacharya
RDRajesh Detroja
Rajesh Detroja
Eugene MerzonEugene Merzon
Eugene Merzon
Milana Frenkel-MorgensternMilana Frenkel-Morgenstern
Milana Frenkel-Morgenstern
Initial clinical trials and surveillance data have shown that the most commonly administered BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA vaccine-induced mild to moderate adverse events were recently reported. Here, we report a rare case of myositis after injection of the first dose of BNT162b2 COVID-19 mRNA vaccine into the left deltoid muscle of a 34-year-old, previously healthy woman who presented progressive proximal muscle weakness, progressive dysphagia, and dyspnea with respiratory failure. One month after vaccination, BNT162b2 vaccine mRNA expression was detected in a tissue biopsy of the right deltoid and quadriceps muscles. We propose this case as a rare example of COVID-19 mRNA vaccine-induced myositis. This study comprehensively characterizes the clinical and molecular features of BNT162b2 mRNA vaccine-associated myositis in which the patient was severely affected.

6 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MBMahua Bhattacharya
Mahua Bhattacharya
DYDan Yaniv
Dan Yaniv
DDDylan P. D’souza
Dylan P. D’souza
EYEyal Yosefof
Eyal Yosefof
STSharon Tzelnick
Sharon Tzelnick
Milana Frenkel-MorgensternMilana Frenkel-Morgenstern
Milana Frenkel-Morgenstern
Background: Circulating cell-free DNA (cfDNA) has been widely used as a prognostic marker for different cancers. Objective: In this study, we used 30 cfDNA samples from oral squamous cell carcinoma (OSCC), 199 public OSCC samples, and 192 normal samples to study various correlation factors that could improve the early-stage diagnostics and/or prognosis of OSCC. Methods: The statistical correlation between healthy and OSCC patients was done and deep sequencing analyses was performed to study various genomic alterations likes copy number variation (CNV), and single nucleotide variants (SNVs), gene fusion and genomic integration of viruses. Results: We found that the OSCC patient cfDNA concentration can serve as an indicator of tumor stage, malignancy, and survival prognosis. Deep genome sequencing of cfDNA revealed genomic alterations, such as CNVs, fusion genes, and viral integrations. The CNV analysis suggested a correlation with amplification and deletion in chromosomes at loci 1q, 2q, 3p, 3q, and chromosome 8 at loci q22. Moreover, at these loci, amplification of TP53, PIK3CA, and other genes related to keratinization in OSCC patients was observed. In addition, we identified a novel abundant fusion gene, TRMO-TRNT1 ‘chimera’, in seven high-grade tumor samples. The parental genes of this chimera, TRMO and TRNT1, are known to play roles in tRNA modification and DNA repair, respectively. We have identified SNVs in our OSCC cohort. Some of these SNVs, like KMT2C, MUC3A, and MUC6, have been identified as common cases in different cancer populations. Finally, we detected contigs integrations of human papillomavirus, simian virus, and enterovirus in the OSCC samples, which may point to the potential causes of OSCC. Conclusions: Our results indicate that the liquid biopsy technique may thus serve as a sensitive tool to study OSCC patient genomic alterations by exploring cfDNA circulating in the plasma, providing an easy-to-use blood test in the future.

5 November 2025 in bioRxiv
Verified
Preprint
Open access
MBMahua Bhattacharya
Mahua Bhattacharya
GBGideon Baum
Gideon Baum
Milana Frenkel-MorgensternMilana Frenkel-Morgenstern
Milana Frenkel-Morgenstern
The expression and functions of genes are largely dependent on genome integrity and stability. Codon usage plays a significant role in maintaining stability and functions of genes. Perturbation in codon sequence can lead to functional and structural dysfunction of a gene. In our study, we performed the codon usage analyses of cell cycle-dependent genes. Various codon usage parameters analyzed using nucleotide compositions like RSCU, ENC, and GC analyses showed that cell cycle dependent genes follow non-optimal codon usage. Genes preferred AT rich ending over GC rich ending, thereby suggesting preference for non-optimal codons. Neutrality and parity plot showed that the codon preference is a result of mutation selection pressure. To study the codon usage implications, we optimized the codons of cell cycle dependent genes (CDK1 and NUF2) to study their effects on cell cycle and apoptosis in vitro. We observed that codon optimization alters the cell cycle length in cell cycle dependent genes impacting cell fate and survival. Our studies revealed that codon usage preferences directly affect the stability of both mRNA and proteins. Specifically, genes and proteins with non optimal codons exhibited reduced stability compared to their optimized counterparts, suggesting critical implications for cell cycle regulation and apoptosis